<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T23:10:27Z</responseDate>
  <request identifier="oai:figshare.com:article/33973387" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33973387</identifier>
        <datestamp>2026-09-23T13:16:12Z</datestamp>
        <setSpec>category_1325</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Oral levamisole as a route-decoupled adjunct to intramuscular foot-and-mouth disease vaccination: a two-species evaluation.pdf</dc:title>
          <dc:creator>Hyeong Won Kim (16010621)</dc:creator>
          <dc:creator>So Hui Park (16010624)</dc:creator>
          <dc:creator>Mi-Kyeong Ko (12405375)</dc:creator>
          <dc:creator>Seokwon Shin (17307466)</dc:creator>
          <dc:creator>Jong-Hyeon Park (304975)</dc:creator>
          <dc:creator>Min Ja Lee (7554740)</dc:creator>
          <dc:subject>Veterinary Anaesthesiology and Intensive Care</dc:subject>
          <dc:subject>foot-and-mouth disease virus</dc:subject>
          <dc:subject>immunomodulation</dc:subject>
          <dc:subject>mice and swine</dc:subject>
          <dc:subject>oral levamisole</dc:subject>
          <dc:subject>route-decoupled</dc:subject>
          <dc:description>Introduction&lt;p&gt;Foot-and-mouth disease (FMD) control still depends largely on inactivated vaccines; however, improving vaccine efficacy without reformulating existing vaccines remains an important practical challenge.&lt;/p&gt;Methods&lt;p&gt;We assessed oral levamisole as an independently administered adjunct alongside, but separately from, a conventional intramuscular bivalent FMD vaccine in mice and FMD-seronegative swine. Serotype-specific immune responses were assessed using structural protein (SP) ELISA and virus-neutralization (VN) assays. IgA-associated responses were examined in mouse serum and saliva and in swine serum, while cytokine-related gene transcription was profiled in porcine peripheral blood mononuclear cells. Murine post-challenge outcomes and porcine safety were also evaluated.&lt;/p&gt;Results&lt;p&gt;Oral levamisole increased antibody and neutralizing responses against FMD virus (FMDV) serotypes O and A in both species. In mice, adjunct treatment improved post-challenge survival (5/5 [100%] with vaccine + levamisole vs. 2/5 [40%] with vaccine alone; log-rank p = 0.004), reduced post-challenge body weight loss, and increased IgA-associated responses.&lt;/p&gt;Discussion&lt;p&gt;These findings support oral levamisole as a practical route-decoupled adjunct for enhancing FMD vaccine responsiveness without requiring modification of the injectable vaccine formulation.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-23T13:16:12Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fvets.2026.1918567.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Oral_levamisole_as_a_route-decoupled_adjunct_to_intramuscular_foot-and-mouth_disease_vaccination_a_two-species_evaluation_pdf/33973387</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
